CEO Jasbir Seehra outlined the company’s development priorities and partnership plans during a presentation at Oppenheimer’s 36th Annual Healthcare Life Sciences conference, highlighting plans to init ...

The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial availability expected during early part of Q2 2026Rare ...

Scientists at the University of California, Irvine's School of Pharmacy & Pharmaceutical Sciences have discovered how muscle stem cells "flip a switch" to rebuild damaged muscle—a finding that could ...

Even if you’re logging strong miles, age-related muscle loss can creep in. The fix is surprisingly straightforward.

A growing body of research is proving that the often discarded portions of an animal are actually the most nutrient dense.

Edgewise Therapeutics Inc., a Boulder-based biopharmaceutical company that develops therapies for muscle disease, spent more on research and development and administration during the fourth quarter of ...

Stem cell therapy performed on babies in the womb could reverse brain abnormalities linked to a severe birth defect, experts ...

This insight explores the $1.1B primary cell market, highlighting how leaders like Lonza, Thermo Fisher, Cloud-Clone, ...

Researchers at the University of Basel have developed a gene therapy that could potentially treat a rare and currently fatal ...

Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced the launch of a new genomics diagnostics initiative centered on two epigenetics-based tests designed to support its clinical trials and expand ...

ATX-04 is a selective β2-adrenergic agonist with human proof-of-concept data demonstrating improved muscle function and enhanced response to ...

Expedition 74 crew members conduct muscle, vein, and respiratory studies aboard the International Space Station to examine microgravity’s effects on blood flow, exercise response, and cardiovascular ...